Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Medtronic financials data including stock price, CreditSafe score, income statement, balance sheet, cash flow, and acquistions and subsidiaries.
Stock Price
$82.8
2023-09-18
Market Capitalization
$120.7 B
2023-05-03
Revenue
$31.2 B
FY, 2023
CreditSafe Score
?
Score changed on Oct 03, 2023
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2021 | FY, 2022 | FY, 2023 |
|---|---|---|---|
| Revenue | 30.1B | 31.7B | 31.2B |
| Cost of goods sold | 10.5B | 10.1B | 10.7B |
| Gross profit | 19.6B | 21.5B | 20.5B |
| Gross profit margin, % | 65.2% | 68.0% | 65.7% |
| General and administrative expense | 10.1B | 10.3B | 10.4B |
| Operating expense total | 15.2B | 15.8B | 15.0B |
| Depreciation and amortization | 1.8B | 1.7B | 1.7B |
| EBIT | 4.5B | 5.8B | 5.5B |
| EBIT margin, % | 14.9% | 18.2% | 17.6% |
| Interest expense | 925.0M | 553.0M | 636.0M |
| Pre tax profit | 3.9B | 5.5B | 5.4B |
| Income tax expense | 265.0M | 456.0M | 1.6B |
| Net Income | 3.6B | 5.1B | 3.8B |
| EPS | 2.7 | 3.7 | 2.8 |
Acquisitions & Subsidiaries
| Company name | Date | Deal size |
|---|---|---|
| Lorem | Dec 23, 2021 | $40.0M |
| Ipsum | Jan 18, 2022 | $30.0M |
| Lorem Ipsum | Feb 18, 2022 | $25.0M |
| Dolor | Oct 21, 2021 | $60.0M |
Premium Content only available in Craft’s Intelligence Portal View acquisitions and subsidiaries by company, date, and deal size. Understanding this data enables better supplier & customer negotiations and helps identify potential opportunities or market risks for your firm. Learn more |